Sara T. Pereira
R&D, AstraZeneca
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 28, 2025
Advancing Cellular-Specific Delivery: Machine Learning Insights into Lipid Nanoparticles Design and Cellular Tropism.
Journal: Advanced healthcare materials
Published: January 22, 2025
RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems.
Journal: Nucleic acids research
Published: March 04, 2024
Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles.
Journal: Small methods
Published: December 23, 2022
Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
Journal: Nanoscale
Published: January 13, 2022
Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: September 23, 2021
Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
Journal: Acta biomaterialia
Published: August 29, 2021
Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids.
Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids.
Journal: International journal of pharmaceutics
Published: April 25, 2021
Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
Journal: Acta biomaterialia
Published: February 22, 2021
Correction to "Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design".
Journal: Molecular pharmaceutics
Published: July 14, 2020
Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 01, 2020
Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 16, 2020
Last Updated: 09/26/2026